Caresyntax raised £140M ($180M) in a Series C extension led by surgical.ai to enhance AI-enabled surgical software and support strategic acquisitions.

Aug 15, 2024•over 1 year ago

Amount Raised

£140 Million

Round Type

series c

San FranciscoHealth CareSoftware

Investors

Surgical.Ai

Description

Surgical.ai has participated in a £140 million ($180 million) Series C extension for Caresyntax. This funding aims to expedite the adoption and development of AI-enabled surgical software while supporting strategic mergers and acquisitions.

Company Information

Company

Caresyntax

Location

San Francisco, California, United States

About

Caresyntax is on a mission to make surgery smarter and safer. Headquartered in San Francisco and Berlin, Caresyntax software is used in more than 4,200 operating rooms worldwide and supports surgical teams in more than three million procedures per year.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends